Keyphrases
Antibody-mediated Rejection
100%
Splenic Irradiation
100%
Splenectomy
80%
Intravenous Immunoglobulin (IVIg)
60%
Plasmapheresis
60%
Transplant Glomerulopathy
60%
Eculizumab
40%
Light Microscopy
20%
Electron Microscopy
20%
Desensitization
20%
Combination Therapy
20%
Kidney Transplant Recipients
20%
Rituximab
20%
Radiation Therapy
20%
Allograft
20%
Graft Function
20%
Adverse Effects
20%
Renal Transplantation
20%
Complication Risk
20%
Living Donor Kidney Transplantation
20%
Comorbid Conditions
20%
After Surgery
20%
Long-term Graft Survival
20%
Antibody Production
20%
Donor-specific Antibodies
20%
Surveillance Biopsy
20%
Graft Protection
20%
Surgical Salvage
20%
Microcirculation Inflammation
20%
Lieu
20%
Immunology and Microbiology
Antibody Mediated Rejection
100%
Intravenous Immunoglobulin
60%
Plasmapheresis
60%
Eculizumab
40%
Electron Microscopy
20%
Light Microscopy
20%
Rituximab
20%
Antibody Production
20%
Microcirculation
20%
Kidney Transplantation
20%
Antibodies
20%
Allograft
20%